Clinical Trial Update: Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation [NA]

View source ↗

Summary

A not-yet-recruiting clinical trial is evaluating clinical and neurobehavioral changes associated with discontinuation and reinitiation of the weight-loss drug …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Substance Use Disorder

Drugs mentioned

• MOUNJARO (tirzepatide)
• Tirzepatide (tirzepatide)

Snippet

Sponsor: The University of Texas at Dallas | Conditions: Drug Discontinuation, Substance Use Disorders | NA | Status: NOT_YET_RECRUITING